Alnylam Pharmaceuticals, Inc.

Mirae Asset Global Investments Co., Ltd. ALNY

Report date

12/31/2025

Quarter

2025 Q4

Filed

1/26/2026

Shares

49,462

Value ($000)

19,669

Weight

0.1%

2019 Q4 - 2025 Q4 (25 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	1/26/2026	19,669	0.1%	49,462	12/31/2025
2025 Q3	11/3/2025	2,809	0.0%	6,160	9/30/2025
2025 Q2	7/21/2025	1,557	0.0%	4,775	6/30/2025
2025 Q1	4/24/2025	1,756	0.0%	6,534	3/31/2025
2024 Q4	1/27/2025	2,164	0.0%	9,130	12/31/2024
2024 Q3	10/23/2024	2,867	0.0%	10,428	9/30/2024
2024 Q2	7/30/2024	3,258	0.0%	13,192	6/30/2024
2024 Q1	5/1/2024	11,164	0.0%	62,415	3/31/2024
2023 Q4	1/24/2024	7,340	0.0%	38,187	12/31/2023
2023 Q3	10/26/2023	10,739	0.0%	60,719	9/30/2023
2023 Q2	8/10/2023	11,113	0.0%	58,451	6/30/2023
2023 Q1	5/4/2023	13,166	0.0%	65,934	3/31/2023
2022 Q4	2/9/2023	13,865	0.0%	58,330	12/31/2022
2022 Q3	11/10/2022	14,626	0.0%	72,691	9/30/2022
2022 Q2	8/15/2022	9,884	0.0%	67,771	6/30/2022
2022 Q1	5/10/2022	10,707	0.0%	65,572	3/31/2022
2021 Q4	2/8/2022	12,759	0.0%	75,169	12/31/2021
2021 Q3	11/15/2021	15,947	0.0%	84,463	9/30/2021
2021 Q2	8/11/2021	11,459	0.0%	67,596	6/30/2021
2021 Q1	5/13/2021	7,887	0.0%	55,864	3/31/2021
2020 Q4	2/10/2021	4,113	0.0%	31,649	12/31/2020
2020 Q3	11/12/2020	2,396	0.0%	16,455	9/30/2020
2020 Q2	8/11/2020	1,984	0.0%	13,392	6/30/2020
2020 Q1	5/12/2020	1,104	0.0%	10,139	3/31/2020
2019 Q4	2/12/2020	1,043	0.0%	9,054	12/31/2019